Search Within

Ravinder K Grewal

Formats
  1. Journal Article (55)
  2. Meeting Abstract (18)
  3. Book Section (4)
  4. Research Letter (2)
  5. Book Whole (1)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (82)
  2. Radiology, Department of (82)
  3. Department of Medicine (56)
  4. Survivorship Research (45)
  5. Division of Subspecialty Medicine (40)
  6. GSK Faculty (40)

More Groups

People
  1. Steven Larson (34)
  2. Robert Tuttle (28)
  3. Heiko Schoder (22)
  4. Alan Ho (16)
  5. James Fagin (15)
  6. Ronald Ghossein (12)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (5)

More Years

Publications
  1. Journal of Nuclear Medicine (11)
  2. Clinical Nuclear Medicine (7)
  3. Journal of Clinical Oncology (7)
  4. Thyroid (7)
  5. Blood (4)
  6. European Journal of Nuclear Medicine and Molecular Imaging (3)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Society of Nuclear Medicine (11)
  3. Lippincott Williams & Wilkins (10)
  4. American Society of Clinical Oncology (7)
  5. Mary Ann Liebert, Inc (7)
  6. Springer (7)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Thyroid cancer brain metastasis: Survival and genomic characteristics of a large tertiary care cohort
    Journal Article

    Osborne, J. R.; Kondraciuk, J. D.; Rice, S. L.; Zhou, X.; Knezevic, A.; Spratt, D. E.; Sabra, M.; Larson, S. M.; Grewal, R. K.
    Clinical Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Enchondroma of tibia as potential false-positive finding on (68)Ga-DOTATOC PET/CT scan
    Journal Article

    Mahajan, S.; Bodei, L.; Huicochea Castellanos, S.; Grewal, R. K.
    Clinical Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Incidental detection of medullary thyroid carcinoma by (68)Ga-DOTATATE PET/CT in a patient with neuroendocrine tumor liver metastases
    Journal Article

    Mahajan, S.; Shaha, A.; Grewal, R. K.
    Clinical Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Redifferentiating thyroid cancer: Selumetinib-enhanced radioiodine uptake in thyroid cancer
    Journal Article

    Larson, S. M.; Osborne, J. R.; Grewal, R. K.; Tuttle, R. M.
    Molecular Imaging and Radionuclide Therapy (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • (68)Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessment: Results of a prospective study on 50 patients
    Journal Article

    Fendler, W. P.; Barrio, M.; Spick, C.; Allen-Auerbach, M.; Ambrosini, V.; Benz, M.; Bluemel, C.; Grewal, R. K.; Lapa, C.; Miederer, M.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Radioiodine dosimetry with recombinant human thyrotropin
    Book Section

    Tuttle, R. M.; Grewal, R. K.; Robbins, R. J.
    In Wartofsky, L.; Van Nostrand, D. (Eds.) Thyroid Cancer: A Comprehensive Guide to Clinical Management. 3rd ed (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save